Literature DB >> 9640845

Substances reactive with mannose-binding protein (MBP) in sera of patients with rheumatoid arthritis.

R Sato1, M Matsushita, M Miyata, Y Sato, R Kasukawa, T Fujita.   

Abstract

OBJECTIVES: In order to evaluate the role of mannose-binding protein (MBP) in rheumatoid arthritis, we characterized MBP-binding substances in sera of patients with this disease.
METHODS: An enzyme linked immunosorbent assay (ELISA) was used to detect MBP-binding substances in sera of patients with RA. We applied the sera of two RA patients to an immobilized MBP column, and by means of both ELISA and molecular sieve chromatography, examined the substances that bound to MBP. MBP-MASP complexes were added to the fractions containing the binding substances, and C4-consuming activity was examined.
RESULTS: Sera of patients with RA showed stronger MBP binding on ELISA than did those of normal controls. In the case of RA sera, both IgG was IgM-RF eluted from the MBP column, whereas with normal controls, only IgG was obtained. The results of molecular sieve chromatography showed that the binding substances of RA patients consisted of immune complexes containing IgG and IgM-RF. These substances were specifically bound to MBP, and once bound, the MBP-MASP complexes were then able to consume C4.
CONCLUSION: MBP binds to immune complexes consisting of IgG and IgM-RF, and probably recognizes either the mannose moiety of IgM-RF or the N-acetyl-glucosamine of agalactosyl IgG. When this occurs in RA patients, the lectin pathway would then be activated.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9640845

Source DB:  PubMed          Journal:  Fukushima J Med Sci        ISSN: 0016-2590


  4 in total

Review 1.  Protective molecules--C-reactive protein (CRP), serum amyloid P (SAP), pentraxin3 (PTX3), mannose-binding lectin (MBL), and apolipoprotein A1 (Apo A1), and their autoantibodies: prevalence and clinical significance in autoimmunity.

Authors:  Martine Szyper Kravitz; Milena Pitashny; Yehuda Shoenfeld
Journal:  J Clin Immunol       Date:  2005-11       Impact factor: 8.317

Review 2.  Glycosylation as a strategy to improve antibody-based therapeutics.

Authors:  Roy Jefferis
Journal:  Nat Rev Drug Discov       Date:  2009-03       Impact factor: 84.694

3.  Mannan binding lectin as an adjunct to risk assessment for myocardial infarction in individuals with enhanced risk.

Authors:  Saedis Saevarsdottir; Oskar Orn Oskarsson; Thor Aspelund; Gudny Eiriksdottir; Thora Vikingsdottir; Vilmundur Gudnason; Helgi Valdimarsson
Journal:  J Exp Med       Date:  2004-12-28       Impact factor: 14.307

4.  Mannose binding lectin and susceptibility to rheumatoid arthritis in Brazilian patients and their relatives.

Authors:  Isabela Goeldner; Thelma L Skare; Shirley R Utiyama; Renato M Nisihara; Hoang van Tong; Iara J T Messias-Reason; Thirumalaisamy P Velavan
Journal:  PLoS One       Date:  2014-04-21       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.